» Articles » PMID: 29201642

The Effect of Duration of Illness and Antipsychotics on Subcortical Volumes in Schizophrenia: Analysis of 778 Subjects

Abstract

Background: The effect of duration of illness and antipsychotic medication on the volumes of subcortical structures in schizophrenia is inconsistent among previous reports. We implemented a large sample analysis utilizing clinical data from 11 institutions in a previous meta-analysis.

Methods: Imaging and clinical data of 778 schizophrenia subjects were taken from a prospective meta-analysis conducted by the COCORO consortium in Japan. The effect of duration of illness and daily dose and type of antipsychotics were assessed using the linear mixed effect model where the volumes of subcortical structures computed by FreeSurfer were used as a dependent variable and age, sex, duration of illness, daily dose of antipsychotics and intracranial volume were used as independent variables, and the type of protocol was incorporated as a random effect for intercept. The statistical significance of fixed-effect of dependent variable was assessed.

Results: Daily dose of antipsychotics was positively associated with left globus pallidus volume and negatively associated with right hippocampus. It was also positively associated with laterality index of globus pallidus. Duration of illness was positively associated with bilateral globus pallidus volumes. Type of antipsychotics did not have any effect on the subcortical volumes.

Discussion: A large sample size, uniform data collection methodology and robust statistical analysis are strengths of the current study. This result suggests that we need special attention to discuss about relationship between subcortical regional brain volumes and pathophysiology of schizophrenia because regional brain volumes may be affected by antipsychotic medication.

Citing Articles

Proposal for a Novel Classification of Patients With Enlarged Ventricles and Cognitive Impairment Based on Data-Driven Analysis of Neuroimaging Results in Patients With Psychiatric Disorders.

Yasuda Y, Ito S, Matsumoto J, Okada N, Onitsuka T, Ikeda M Neuropsychopharmacol Rep. 2025; 45(1):e70010.

PMID: 40011069 PMC: 11864853. DOI: 10.1002/npr2.70010.


Epigenome Defines Aberrant Brain Laterality in Major Mental Illnesses.

Mostafavi Abdolmaleky H, Nohesara S, Thiagalingam S Brain Sci. 2024; 14(3).

PMID: 38539649 PMC: 10968810. DOI: 10.3390/brainsci14030261.


Brain Structural Changes in Schizophrenia Patients Compared to the Control: An MRI-based Cavalieri's Method.

Heidari Z, Mahmoudzadeh-Sagheb H, Shakiba M, Charkhat Gorgich E Basic Clin Neurosci. 2023; 14(3):355-363.

PMID: 38077177 PMC: 10700815. DOI: 10.32598/bcn.2021.3481.1.


Subcortical volumetric alterations in four major psychiatric disorders: a mega-analysis study of 5604 subjects and a volumetric data-driven approach for classification.

Okada N, Fukunaga M, Miura K, Nemoto K, Matsumoto J, Hashimoto N Mol Psychiatry. 2023; 28(12):5206-5216.

PMID: 37537281 PMC: 11041797. DOI: 10.1038/s41380-023-02141-9.


Transcriptional level of inflammation markers associates with short-term brain structural changes in first-episode schizophrenia.

Cui L, Wang X, Fu Y, Liu X, Wei Y, Zhao S BMC Med. 2023; 21(1):250.

PMID: 37424013 PMC: 10332052. DOI: 10.1186/s12916-023-02963-y.


References
1.
Woods B, Ward K, Johnson E . Meta-analysis of the time-course of brain volume reduction in schizophrenia: implications for pathogenesis and early treatment. Schizophr Res. 2005; 73(2-3):221-8. DOI: 10.1016/j.schres.2004.05.014. View

2.
Keshavan M, Bagwell W, Haas G, Sweeney J, Schooler N, Pettegrew J . Changes in caudate volume with neuroleptic treatment. Lancet. 1994; 344(8934):1434. DOI: 10.1016/s0140-6736(94)90599-1. View

3.
Frazier J, Giedd J, Kaysen D, Albus K, HAMBURGER S, Alaghband-Rad J . Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am J Psychiatry. 1996; 153(4):564-6. DOI: 10.1176/ajp.153.4.564. View

4.
Navari S, Dazzan P . Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol Med. 2009; 39(11):1763-77. DOI: 10.1017/S0033291709005315. View

5.
Kubota M, van Haren N, Haijma S, Schnack H, Cahn W, Hulshoff Pol H . Association of IQ Changes and Progressive Brain Changes in Patients With Schizophrenia. JAMA Psychiatry. 2015; 72(8):803-12. DOI: 10.1001/jamapsychiatry.2015.0712. View